CN111529660A - Antiviral traditional Chinese medicine - Google Patents
Antiviral traditional Chinese medicine Download PDFInfo
- Publication number
- CN111529660A CN111529660A CN202010330008.XA CN202010330008A CN111529660A CN 111529660 A CN111529660 A CN 111529660A CN 202010330008 A CN202010330008 A CN 202010330008A CN 111529660 A CN111529660 A CN 111529660A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- radix
- lily
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Pulmonology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to an antiviral traditional Chinese medicine, which is characterized in that: the traditional Chinese medicine composition is prepared from the following raw material medicines in the weight range: ephedra, cassia twig, almond, liquorice, aster, common coltsfoot flower, sessile stemona root, lily, astragalus, codonopsis pilosula, largehead atractylodes rhizome, Indian buead, blackberry lily, indigowoad root, turmeric root-tuber, malaytea scurfpea fruit, Chinese angelica, fritillary bulb, processed pinellia tuber, loquat leaf, Chinese magnoliavine fruit, vinegar-processed spina gleditsiae, divaricate saposhnikovia root and fineleaf schizo. The dosage form is decoction, powder or pill. Can rapidly remove viruses in the body and restore the vital qi and functions of the human body. Has effects in dispersing lung qi, inducing perspiration, eliminating phlegm, relieving asthma and cough, removing blood stasis, relieving swelling, resisting inflammation, resisting bacteria and virus, relieving fever, and enhancing immunity. Has good treatment effect on patients infected with virus at the initial stage, without obvious symptoms or slight symptoms and with fever, and has particularly obvious effect.
Description
Technical Field
The invention relates to the field of traditional Chinese medicines, in particular to an antiviral traditional Chinese medicine.
Background
In the high-incidence season of epidemic diseases, the influenza virus is mixed with a novel coronavirus, and belongs to cold-dampness epidemic virus in nature. Cold-damp epidemic toxin closes the lung and accumulates to transform heat, thereby forming symptoms such as cough, phlegm, asthma, heat and the like; cold-dampness obstructing the spleen causes dysfunction of the spleen in transportation and transformation, resulting in abdominal distension and loose stool. The invention takes Zhongjing ephedra decoction as a basic formula, and is added with the divaricate saposhnikovia root and the fineleaf schizonepeta herb to ventilate and perspire the lung, so that cold-dampness epidemic toxins (influenza viruses, novel coronavirus and the like) are discharged out of the body along with the sweat, thereby recovering the functions of diffusing, purifying and descending the lung.
Disclosure of Invention
The technical problem to be solved by the invention is as follows: overcomes the defects of the prior art and provides an antiviral traditional Chinese medicine.
The technical scheme for solving the technical problem is as follows: an antiviral traditional Chinese medicine is characterized in that: the traditional Chinese medicine composition comprises the following raw material medicines in parts by weight: 3-10 parts of ephedra, 3-10 parts of cassia twig, 3-10 parts of almond, 3-10 parts of liquorice, 5-15 parts of aster, 5-15 parts of flos farfarae, 5-15 parts of radix stemonae, 10-30 parts of lily, 10-15 parts of astragalus membranaceus, 10-30 parts of codonopsis pilosula, 5-15 parts of bighead atractylodes rhizome, 9-15 parts of poria cocos, 6-15 parts of blackberrylily rhizome, 15-30 parts of isatis root, 5-12 parts of radix curcumae, 5-15 parts of fructus psoraleae, 6-12 parts of angelica sinensis, 3-10 parts of fritillaria, 3-10 parts of prepared pinellia tuber, 5-15 parts of loquat leaf, 3-6 parts of schisandra chinensis, 3-15 parts of vinegar-prepared spina gleditsiae, 5-10 parts of radix sileris and 5.
Adding 15-60 parts of gypsum for patients with fever or high fever symptoms
The antiviral traditional Chinese medicine comprises the following raw material medicines in parts by weight: 6 parts of ephedra, 10 parts of cassia twig, 10 parts of almond, 10 parts of liquorice, 15 parts of aster, 15 parts of common coltsfoot flower, 15 parts of radix stemonae, 10 parts of lily, 15 parts of astragalus mongholicus, 15 parts of codonopsis pilosula, 10 parts of bighead atractylodes rhizome, 10 parts of poria cocos, 15 parts of blackberry lily, 15 parts of radix isatidis, 10 parts of radix curcumae, 10 parts of fructus psoraleae, 12 parts of angelica sinensis, 10 parts of fritillaria, 10 parts of prepared pinellia ternate, 15 parts of loquat leaf, 6 parts of schisandra chinensis, 15 parts of vinegar-prepared spina gleditsiae, 10 parts of radix sileris.
For patients with fever or high fever symptoms, 15 parts of gypsum are added.
The dosage form of the antiviral traditional Chinese medicine is decoction, powder or pill.
The decoction of the antiviral traditional Chinese medicine is taken by the following method: the raw material medicines are mixed together to be decocted in water for taking 1 g of each part, one part of the raw material medicines is decocted in water for 2 times, the mixture is taken in three times, the medicines are taken once in the morning and at night, and the medicine is taken half a day warmly.
The powder of the antiviral traditional Chinese medicine is taken by the following method: the raw materials are mixed together and crushed into powder, the powder is filled into filter paper bags, each bag is 8 g, 4 bags are used every day, and the filter paper bags are brewed with boiled water and drunk as tea.
The pill of the antiviral traditional Chinese medicine is taken by the following method: the raw materials are mixed together and crushed into powder, and the powder is sieved to prepare water pills, the diameter of each pill is 6 mm, each time is 8 g, the pill is taken 3 times a day and is taken once in the morning, noon and evening with warm boiled water.
The decoction, powder or pill of the antiviral traditional Chinese medicine is taken by the following method: the children are halved.
The taking notice of the antiviral traditional Chinese medicine is as follows: if the medicine does not sweat after half an hour, the hot porridge is drunk to help sweating and slightly sweat.
Ephedra, cassia twig, almond, liquorice, radix sileris and herba schizonepetae are used for ventilating the lung and sweating, so that cold-dampness epidemic toxin (influenza virus and novel coronavirus) is discharged out of the body along with sweat, thereby recovering the functions of ventilating, purifying and descending the lung, and the medicine is a monarch medicine; the aster, the flos farfarae, the radix stemonae, the fritillaria, the prepared pinellia ternate, the lily, the schisandra chinensis and the loquat leaves can moisten lung, reduce phlegm, astringe lung, relieve cough and help monarch drugs to recover the dispersing and descending functions of lung, and are ministerial drugs; the blackberrylily rhizome and the isatis root have antiviral effect, can clear away heat and toxic materials, remove stasis and heat from the turmeric root-tuber, recover the dispersing and descending functions of the lung, and are ministerial drugs; radix astragali, radix Codonopsis, Atractylodis rhizoma, Poria, Glycyrrhrizae radix, radix Angelicae sinensis, and fructus Psoraleae can be used as adjuvant drugs for invigorating qi and blood, invigorating spleen, warming kidney, activating spleen, eliminating dampness, strengthening earth, benefiting gold, and improving body resistance to cold-dampness and epidemic toxin; the spina gleditsiae processed by vinegar can remove blood stasis, relieve swelling and kill viruses, and like a sharp knife, can quickly recover deep tissues invaded by viruses and lead the medicines to directly reach the focus, thereby serving as a guiding medicine.
The combined forces of the monarch, the minister, the assistant and the envoy can quickly dispel viruses in the body and restore the vital qi and functions of the human body.
The invention has the beneficial effects that: the new coronavirus "nail protein" attacks the epithelial surface of the lung, and after the virus enters the cell, the virus is synthesized into new virus through a chemical reaction and released outside the cell to attack the rest lung cells. Practice shows that astragalus, codonopsis pilosula, bighead atractylodes rhizome, poria cocos, angelica sinensis and the like have the immune function of enhancing human body cells, the cells with the immune function recognize and surround virus-infected cells for phagocytosis, and meanwhile, the targeting effect of spina gleditsiae is utilized to kill viruses together with isatis root, blackberry lily and the like, so that the human body immune cells are helped to kill and clear the viruses out, and the viruses are discharged out of the body through metabolism. And a part of viruses are removed from the body through sweat due to the sweating effect of the ephedra decoction, are taken together and are combined inside and outside, so that the normal operation of the dispersing and descending functions of the lung is kept, and a human body is kept to normally operate without being influenced by virus infection.
Clinical practices prove that the traditional Chinese medicine composition has the effects of ventilating the lung, inducing perspiration, reducing phlegm, relieving asthma, relieving cough, removing blood stasis, relieving swelling, resisting inflammation, bacteria and viruses, reducing fever, enhancing the immunity of the organism and the like.
The invention has good treatment effect on patients who have no obvious symptoms or slight symptoms of initial infection viruses, and the effect is particularly obvious.
Detailed Description
The present invention is further illustrated by the following examples.
Example 1, this example is applied to an adult patient infected with virus at the initial stage and having no obvious symptoms, and is taken with a decoction, and the decoction is composed of the following raw material medicines in parts by weight: 6 parts of ephedra, 10 parts of cassia twig, 10 parts of almond, 10 parts of liquorice, 15 parts of aster, 15 parts of common coltsfoot flower, 15 parts of radix stemonae, 10 parts of lily, 15 parts of astragalus mongholicus, 15 parts of codonopsis pilosula, 10 parts of bighead atractylodes rhizome, 10 parts of poria cocos, 15 parts of blackberry lily, 15 parts of radix isatidis, 10 parts of radix curcumae, 10 parts of fructus psoraleae, 12 parts of angelica sinensis, 10 parts of fritillaria, 10 parts of prepared pinellia ternate, 15 parts of loquat leaf, 6 parts of schisandra chinensis, 15 parts of vinegar-prepared spina gleditsiae, 10 parts of radix sileris.
The administration method comprises the following steps: the raw material medicines are mixed together to be decocted in water for taking 1 g of each part, one part of the raw material medicines is decocted in water for 2 times, the mixture is taken in three times, the medicines are taken once in the morning and at night, and the medicine is taken half a day warmly.
Example 2, this example is applied to an adult patient infected with virus at an early stage and having no obvious symptoms, and the patient has fever symptoms, and the decoction is taken, and the decoction is composed of the following raw material medicines in parts by weight: 6 parts of ephedra, 10 parts of cassia twig, 10 parts of almond, 10 parts of liquorice, 15 parts of aster, 15 parts of common coltsfoot flower, 15 parts of radix stemonae, 10 parts of lily, 15 parts of astragalus membranaceus, 15 parts of codonopsis pilosula, 10 parts of bighead atractylodes rhizome, 10 parts of poria cocos, 15 parts of blackberry lily, 15 parts of radix isatidis, 10 parts of radix curcumae, 10 parts of fructus psoraleae, 12 parts of angelica sinensis, 10 parts of fritillaria, 10 parts of prepared pinellia ternate, 15 parts of loquat leaf, 6 parts of schisandra chinensis, 15 parts of vinegar-prepared spina gleditsiae, 10 parts of radix sileris, 10 parts of schizo.
The administration method comprises the following steps: the raw material medicines are mixed together to be decocted in water for taking 1 g of each part, one part of the raw material medicines is decocted in water for 2 times, the mixture is taken in three times, the medicines are taken once in the morning and at night, and the medicine is taken half a day warmly.
Example 3, this example is applied to an adult patient infected with virus at the initial stage and having no obvious symptoms, and the patient has fever symptoms, and the decoction is taken, and the decoction is composed of the following raw material medicines in parts by weight: 6 parts of ephedra, 10 parts of cassia twig, 10 parts of almond, 10 parts of liquorice, 15 parts of aster, 15 parts of common coltsfoot flower, 15 parts of radix stemonae, 10 parts of lily, 15 parts of astragalus membranaceus, 15 parts of codonopsis pilosula, 10 parts of bighead atractylodes rhizome, 10 parts of poria cocos, 15 parts of blackberry lily, 15 parts of radix isatidis, 10 parts of radix curcumae, 10 parts of fructus psoraleae, 12 parts of angelica sinensis, 10 parts of fritillaria, 10 parts of prepared pinellia ternate, 15 parts of loquat leaf, 6 parts of schisandra chinensis, 15 parts of vinegar-prepared spina gleditsiae, 10 parts of radix sileris, 10 parts of schizo.
The administration method comprises the following steps: the raw material medicines are mixed together to be decocted in water for taking 1 g of each part, one part of the raw material medicines is decocted in water for 2 times, the mixture is taken in three times, the medicines are taken once in the morning and at night, and the medicine is taken half a day warmly.
After half an hour of taking the porridge, no sweating occurs, and the porridge can help sweating and slightly sweat after being drunk.
Example 4, this example is for an adult patient with early stage infection with virus and mild symptoms, and is administered in powder, and comprises the following raw material drugs in parts by weight: 6 parts of ephedra, 10 parts of cassia twig, 10 parts of almond, 10 parts of liquorice, 15 parts of aster, 15 parts of common coltsfoot flower, 15 parts of radix stemonae, 10 parts of lily, 15 parts of astragalus mongholicus, 15 parts of codonopsis pilosula, 10 parts of bighead atractylodes rhizome, 10 parts of poria cocos, 15 parts of blackberry lily, 15 parts of radix isatidis, 10 parts of radix curcumae, 10 parts of fructus psoraleae, 12 parts of angelica sinensis, 10 parts of fritillaria, 10 parts of prepared pinellia ternate, 15 parts of loquat leaf, 6 parts of schisandra chinensis, 15 parts of vinegar-prepared spina gleditsiae, 10 parts of radix sileris.
The administration method comprises the following steps: the raw materials are mixed together and crushed into powder, the powder is filled into filter paper bags, each bag is 8 g, 4 bags are used every day, and the filter paper bags are brewed with boiled water and drunk as tea.
Example 5, this example is applied to adult patients with early stage infection of virus and mild symptoms, and is taken in pills, which is composed of the following raw material medicines in parts by weight: 6 parts of ephedra, 10 parts of cassia twig, 10 parts of almond, 10 parts of liquorice, 15 parts of aster, 15 parts of common coltsfoot flower, 15 parts of radix stemonae, 10 parts of lily, 15 parts of astragalus mongholicus, 15 parts of codonopsis pilosula, 10 parts of bighead atractylodes rhizome, 10 parts of poria cocos, 15 parts of blackberry lily, 15 parts of radix isatidis, 10 parts of radix curcumae, 10 parts of fructus psoraleae, 12 parts of angelica sinensis, 10 parts of fritillaria, 10 parts of prepared pinellia ternate, 15 parts of loquat leaf, 6 parts of schisandra chinensis, 15 parts of vinegar-prepared spina gleditsiae, 10 parts of radix sileris.
The administration method comprises the following steps: the raw materials are mixed together and crushed into powder, and the powder is sieved to prepare water pills, the diameter of each pill is 6 mm, each time is 8 g, the pill is taken 3 times a day and is taken once in the morning, noon and evening with warm boiled water.
Example 6, this example is for an adult patient with early stage infection with virus and mild symptoms, who has fever symptoms and takes pills, and the pills are composed of the following raw material medicines in parts by weight: 6 parts of ephedra, 10 parts of cassia twig, 10 parts of almond, 10 parts of liquorice, 15 parts of aster, 15 parts of common coltsfoot flower, 15 parts of radix stemonae, 10 parts of lily, 15 parts of astragalus membranaceus, 15 parts of codonopsis pilosula, 10 parts of bighead atractylodes rhizome, 10 parts of poria cocos, 15 parts of blackberry lily, 15 parts of radix isatidis, 10 parts of radix curcumae, 10 parts of fructus psoraleae, 12 parts of angelica sinensis, 10 parts of fritillaria, 10 parts of prepared pinellia ternate, 15 parts of loquat leaf, 6 parts of schisandra chinensis, 15 parts of vinegar-prepared spina gleditsiae, 10 parts of radix sileris, 10 parts of schizo.
The administration method comprises the following steps: the raw materials are mixed together and crushed into powder, and the powder is sieved to prepare water pills, the diameter of each pill is 6 mm, each time is 8 g, the pill is taken 3 times a day and is taken once in the morning, noon and evening with warm boiled water.
After the porridge is taken for a half hour, no sweating occurs, and the porridge is drunk to help sweating and slightly sweat.
Example 7, this example is applied to children patients with early stage infection of virus and mild symptoms, and is taken in pills, which are composed of the following raw material medicines in parts by weight: 3 parts of ephedra, 5 parts of cassia twig, 5 parts of almond, 5 parts of liquorice, 7.5 parts of aster, 7.5 parts of common coltsfoot flower, 7.5 parts of sessile stemona root, 5 parts of lily, 7.5 parts of astragalus root, 7.5 parts of pilose asiabell root, 5 parts of largehead atractylodes rhizome, 5 parts of tuckahoe, 7.5 parts of blackberry lily, 7.5 parts of isatis root, 5 parts of turmeric root-tuber, 5 parts of malaytea scurfpea fruit, 6 parts of Chinese angelica, 5 parts of fritillary bulb, 5 parts of prepared pinellia tuber, 7.5 parts of loquat leaf, 3 parts of Chinese magnoliavine fruit, 7.5 parts of vinegar-prepared spina gleditsiae.
The administration method comprises the following steps: the raw materials are mixed together and crushed into powder, and the powder is sieved to prepare water pills, the diameter of each pill is 6 mm, 4 g of the water pills are taken, 3 times a day, and once in the morning, noon and evening, and the water pills are taken with warm boiled water.
The present invention is not limited to the present embodiment, and it is possible for those skilled in the art to easily reproduce and modify the present invention without inventive efforts within the scope of the present invention claimed.
Claims (5)
1. An antiviral traditional Chinese medicine is characterized in that: the traditional Chinese medicine composition comprises the following raw material medicines in parts by weight: 3-10 parts of ephedra, 3-10 parts of cassia twig, 3-10 parts of almond, 3-10 parts of liquorice, 5-15 parts of aster, 5-15 parts of flos farfarae, 5-15 parts of radix stemonae, 10-30 parts of lily, 10-15 parts of astragalus membranaceus, 10-30 parts of codonopsis pilosula, 5-15 parts of bighead atractylodes rhizome, 9-15 parts of poria cocos, 6-15 parts of blackberrylily rhizome, 15-30 parts of isatis root, 5-12 parts of radix curcumae, 5-15 parts of fructus psoraleae, 6-12 parts of angelica sinensis, 3-10 parts of fritillaria, 3-10 parts of prepared pinellia tuber, 5-15 parts of loquat leaf, 3-6 parts of schisandra chinensis, 3-15 parts of vinegar-prepared spina gleditsiae, 5-10 parts of radix sileris and 5.
2. The antiviral traditional Chinese medicine as claimed in claim 1, which is characterized in that: adding 15-60 parts of gypsum.
3. The antiviral traditional Chinese medicine as claimed in claim 1, which is characterized in that: the raw material medicines in parts by weight are as follows: 6 parts of ephedra, 10 parts of cassia twig, 10 parts of almond, 10 parts of liquorice, 15 parts of aster, 15 parts of common coltsfoot flower, 15 parts of radix stemonae, 10 parts of lily, 15 parts of astragalus mongholicus, 15 parts of codonopsis pilosula, 10 parts of bighead atractylodes rhizome, 10 parts of poria cocos, 15 parts of blackberry lily, 15 parts of radix isatidis, 10 parts of radix curcumae, 10 parts of fructus psoraleae, 12 parts of angelica sinensis, 10 parts of fritillaria, 10 parts of prepared pinellia ternate, 15 parts of loquat leaf, 6 parts of schisandra chinensis, 15 parts of vinegar-prepared spina gleditsiae, 10 parts of radix sileris.
4. The antiviral traditional Chinese medicine as claimed in claim 2, which is characterized in that: adding 15 parts of gypsum.
5. An antiviral traditional Chinese medicine as claimed in claim 1 and/or 2 and/or 3 and/or 4, which is characterized in that: the dosage form of the antiviral traditional Chinese medicine is decoction, powder or pill.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010330008.XA CN111529660A (en) | 2020-04-24 | 2020-04-24 | Antiviral traditional Chinese medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010330008.XA CN111529660A (en) | 2020-04-24 | 2020-04-24 | Antiviral traditional Chinese medicine |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111529660A true CN111529660A (en) | 2020-08-14 |
Family
ID=71973345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010330008.XA Pending CN111529660A (en) | 2020-04-24 | 2020-04-24 | Antiviral traditional Chinese medicine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111529660A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110731988A (en) * | 2019-10-11 | 2020-01-31 | 安徽九华华源药业有限公司 | novel ephedra soup, preparation method and application |
CN110870402A (en) * | 2020-02-06 | 2020-03-06 | 葛又文 | Prescription for treating pneumonia infected by novel coronavirus and application thereof |
-
2020
- 2020-04-24 CN CN202010330008.XA patent/CN111529660A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110731988A (en) * | 2019-10-11 | 2020-01-31 | 安徽九华华源药业有限公司 | novel ephedra soup, preparation method and application |
CN110870402A (en) * | 2020-02-06 | 2020-03-06 | 葛又文 | Prescription for treating pneumonia infected by novel coronavirus and application thereof |
Non-Patent Citations (2)
Title |
---|
祁沛: "射干麻黄汤在小儿肺炎中的应用", 《陕西医药杂志》 * |
韦宗境: "复方芪芩汤治疗小儿迁延性病毒性肺炎 43 例", 《浙江中医杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107303383A (en) | A kind of Chinese medicine composition and its derivative and product to a variety of symptoms with effect | |
CN103230548B (en) | Traditional Chinese medicine composition for treating pulmonary heart disease | |
CN101912484A (en) | Chinese medicinal composition for treating hypertension, hyperlipidemia and hyperglycemia | |
CN113521232B (en) | A Chinese medicinal composition containing Atractylodis rhizoma | |
CN104013926A (en) | Traditional Chinese medicine composition and application of traditional Chinese medicine composition as medicine for treating fatty liver | |
CN103520395B (en) | Traditional Chinese medicine composition for treating lung cancer | |
CN103301267B (en) | Traditional Chinese medicine composition for treating hypertension and/or atherosclerosis and application thereof | |
CN102247479A (en) | Antitumor strong medicine and preparation method thereof | |
CN104621310A (en) | Health tea and application thereof | |
CN104189764A (en) | Traditional Chinese medicinal preparation for treating intervention postoperative fever | |
CN111529660A (en) | Antiviral traditional Chinese medicine | |
CN103877483A (en) | Traditional Chinese medicine for treating chronic gastritis and preparation method thereof | |
CN101884729A (en) | Chinese medicinal preparation for treating allergic asthma | |
CN105920557B (en) | Changlingweishu tablet and its preparation process | |
CN100364605C (en) | Specific pellet for treating cold, and preparation method | |
CN104491735A (en) | Traditional Chinese medicine formula for treating kidney tumor | |
CN104127578B (en) | Traditional Chinese medicine composition for treating acute or chronic rhinitis and preparation method thereof | |
CN103705731A (en) | Traditional Chinese medicine composition for treating chronic alcoholic toxic liver disease | |
CN103394064A (en) | Traditional Chinese medicine composition used for treating slight cold | |
CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
CN102552789A (en) | Chinese medicine for treating damp-warm flu and preparation method and application thereof | |
CN118384239A (en) | Composition for strengthening body resistance and preventing and treating new crown and preparation method thereof | |
CN105362819A (en) | Traditional Chinese medicinal preparation for treating pleurisy and preparation method of traditional Chinese medicinal preparation | |
CN112023005A (en) | Traditional Chinese medicine preparation for treating viral hepatitis and preparation method thereof | |
CN104984004A (en) | Oral medicine for treating whole body lymphadenectasis and preparing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |